Most just lately, it has been identified that conolidine and the above mentioned derivatives act around the atypical chemokine receptor 3 (ACKR3. Expressed in very similar locations as classical opioid receptors, it binds to some big selection of endogenous opioids. Not like most opioid receptors, this receptor acts like a scavenger and won't activ… Read More


These results, together with a prior report exhibiting that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 assist the notion of targeting ACKR3 as a singular solution to modulate the opioid system, which could open up new therapeutic avenues for opioid-similar Diseases.Disclaimer: The above is often a sponsored ar… Read More